R

ReNAgade Therapeutics

Cambridge, United States Founded 2021

About

RNA delivery technology for extrahepatic targets

Company Details

Type
commercial
Employees
100-200
Funding
$300M+

Key Products

  • Tissue-Selective RNA Delivery
Visit Website

Related Companies